Macro-economic development of China's health industry is essential to the sustainable development and growth momentum of the national economy. Strategies to promote the development and rebalancing of the industrial structure need to be improved in order to transform China's health industry and drive development. Based on panel data of 25 regions in China from 2004 to 2016, this paper analyzes the linear and non-linear relationship between Chinese government health expenditure (GHE), GHE efficiency, and the macro-economic development of the health industry. It uses a novel index of industrial structure to measure the transformation of industrial sectors in China, based on a semi-parametric generalized additive model. The model shows that per capita GHE and its efficiency have a significant positive linear and comprehensive non-linear effect on the development of health industry structure. By analyzing the interaction of GHE and its efficiency, we show that high expenditure with low-efficiency regimes and high expenditure with high-efficiency regimes have a positive impact on the development of industrial structure. Following the empirical results, the paper puts forward corresponding policy suggestions for the role of fiscal policy in promoting the development of the health industry in China.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432442 | PMC |
| http://dx.doi.org/10.3390/ijerph17155529 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Validation of the PANAMA-Score for Survival and Benefit of Adjuvant Therapy in Patients with Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX.
Ann Surg
January 2025
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Aim: To validate the prognostic value of the PAncreatic NeoAdjuvant MAssachusetts (PANAMA)-score and to determine its predictive ability for survival benefit derived from adjuvant treatment in patients after resection of pancreatic ductal adenocarcinoma (PDAC) following neoadjuvant FOLFIRINOX.
Background: The PANAMA-score was developed to guide prognostication in patients after neoadjuvant therapy and resection for PDAC. As this score focuses on the risk for residual disease after resection, it might also be able to select patients who benefit from adjuvant after neoadjuvant therapy.
Insight into the Synergistic Effect of Binary Nonmetallic Codoped CoO Catalysts for Efficient Ethyl Acetate Degradation under Humid Conditions.
JACS Au
January 2025
School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.
The synthesis of high-performance catalysts for volatile organic compounds (VOCs) degradation under humid conditions is essential for their practical industrial application. Herein, a codoping strategy was adopted to synthesize the N-CoO-C catalyst with N, C codoping for low-temperature ethyl acetate (EA) degradation under humid conditions. Results showed that N-CoO-C exhibited great catalytic activity ( = 177 °C) and water resistance (5.
View Article and Find Full Text PDFWorkload in the Austrian IT-sector regarding leadership roles.
Front Sociol
January 2025
Sigmund Freud University Vienna, Faculty of Psychotherapy Science, Vienna, Austria.
This paper investigates the impact of workload on leadership roles within the Austrian IT sector, by also paying attention to differences between genders. The research adopted a prospective design, selecting IT professionals, stratified by those with and without personnel responsibility and examined further through the lens of gender. A total of 200 participants completed the survey, where the modified German version of the Copenhagen Psychosocial Questionnaire (COPSOQ) served as the primary tool, which evaluated dimensions such as demands, influence, interpersonal relations, work interface, and conflicts.
View Article and Find Full Text PDFGlobalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities.
BMJ Oncol
September 2023
Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.
Objective: Breast, lung, colon cancers are the 'big killers' in oncology. Access to innovative treatments lags behind in low-income and middle-income countries. We investigated the geographic distribution of industry-sponsored trials; and whether results were reported in clinical trial registries.
View Article and Find Full Text PDFShort-term Assessment of Glaucoma Progression in Clinical Trials Using Trend-based Visual Field Progression Analysis.
Ophthalmol Sci
November 2024
Department of Ophthalmology, National Center for Global Health and Medicine, Tokyo, Japan.
Objective: To evaluate the effect of disease stage, frequency and clustering of visual field (VF) tests, inclusion of 1 or both eyes, and 1 (1 arm; before and after a treatment) or 2 groups (2 arms; treatment and control arm) on sample size calculation in clinical trials.
Design: Clinical cohort study.
Participants: A series of VFs were simulated based on test-retest VF data in the early, moderate, and advanced stages of glaucoma with 231, 204, and 226 eyes, respectively.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!